Shares of Gilead Sciences Inc.
inched 0.77% higher to $68.15 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index
rising 1.71% to 4,438.26 and the Dow Jones Industrial Average
rising 1.56% to 34,912.56. This was the stock's second consecutive day of gains. Gilead Sciences Inc. closed $5.19 short of its 52-week high ($73.34), which the company achieved on August 18th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson
rose 0.57% to $160.11, Merck & Co. Inc.
fell 0.79% to $78.33, and AbbVie Inc.
rose 1.57% to $108.91. Trading volume (7.1 M) eclipsed its 50-day average volume of 6.2 M.